• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

喀麦隆从事性交易女性的健康保险成本效益及其对艾滋病毒传播的影响:一个数学模型

Cost-effectiveness of health insurance among women engaged in transactional sex and impacts on HIV transmission in Cameroon: a mathematical model.

作者信息

Allel Kasim, Cust Henry, Mfochive Iliassou, Szawlowski Sandie, Nitcheu Emile, Tamgno Eric Defo, Moyoum Stephanie, Noo Julienne, Billong Serge, Tamoufe Ubald, Lepine Aurelia

机构信息

University College London, London, UK

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

BMJ Glob Health. 2025 Feb 18;10(2):e017870. doi: 10.1136/bmjgh-2024-017870.

DOI:10.1136/bmjgh-2024-017870
PMID:39965863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11836847/
Abstract

INTRODUCTION

HIV prevalence disproportionately affects high-risk populations, particularly female sex workers in Africa. Women and girls engaging in transactional sex (WGTS) face similar health risks from unsafe practices, economic vulnerabilities and stigma. However, they are not recognised.

METHODS

Using existing literature and data from the POWER randomised controlled trial, we developed a deterministic compartmental model to assess HIV dynamics among WGTS, their sugar daddies and low-risk populations. We evaluated the cost-effectiveness of a new structural intervention to prevent HIV among WGTS in urban Cameroon by reducing the financial need to engage in transactional sex in the case of illness and injury shocks to the household. The intervention provided free healthcare to WGTS and their economic dependents through a zero-cost health insurance package. We explored the cost-effectiveness of this intervention considering various population coverage levels (0%, 25%, 50%, 75% and 100%). We calculated the incremental cost-effectiveness ratio (ICER) per disability-adjusted life-year (DALY) and HIV infections averted, employing both univariable and global sensitivity analyses. Probabilistic sensitivity analyses considered all parameters, including the insurance effect in reducing HIV, comparing simulated ICERs to willingness-to-pay thresholds. We also compared the health insurance strategy with expanding pre-exposure prophylaxis (PrEP) coverage. All costs were evaluated in 2023 UK pounds (£) using a 3% discount rate, with Cameroon's gross domestic product (GDP) per capita recorded at £1239.

RESULTS

Implementing health insurance coverage levels of 25%, 50%, 75% and 100% yielded ICERs/DALY averted of £2795 (£2483-£2824), £2541 (£2370-£2592), £2263 (£2156-£2316) and £1952 (£1891-£1998), respectively, compared with 0% coverage. Probabilistic sensitivity analysis indicated an ICER=£2128/DALY averted at 100% coverage, with 58% of simulations showing ICERs<GDP per capita. Maintaining health insurance's effect in reducing HIV above 70% could provide significant health and economic benefits. However, antiretroviral therapy (ART) efficacy significantly impacted HIV infection prevention (partial rank correlation coefficient=-0.62, p<0.001) in global sensitivity analyses; expanding ART could reduce the cost-effectiveness of health insurance. While PrEP alone is not cost-effective, combining 20% PrEP coverage with 75%-100% health insurance for WGTS maximises DALYs averted (ICER/DALY averted=£2436-£2102) and reduces infections.

CONCLUSION

A comprehensive health insurance scheme for women in Cameroon could significantly reduce HIV infections and DALYs, promoting a more inclusive and targeted healthcare policy for women at high risk of HIV.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30f/11836847/00e98d96db9b/bmjgh-10-2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30f/11836847/c908c0cb7be5/bmjgh-10-2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30f/11836847/00e98d96db9b/bmjgh-10-2-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30f/11836847/c908c0cb7be5/bmjgh-10-2-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b30f/11836847/00e98d96db9b/bmjgh-10-2-g002.jpg

引言

艾滋病毒流行对高危人群的影响尤为严重,在非洲,女性性工作者受影响的比例过高。从事交易性性行为的妇女和女孩面临着因不安全行为、经济脆弱性和耻辱感带来的类似健康风险。然而,她们并未得到认可。

方法

利用现有文献和POWER随机对照试验的数据,我们开发了一个确定性的房室模型,以评估从事交易性性行为的妇女及其“糖爹”和低风险人群中的艾滋病毒动态。我们通过减少家庭因病伤冲击而从事交易性性行为的经济需求,评估了一种新的结构性干预措施在喀麦隆城市预防从事交易性性行为妇女感染艾滋病毒的成本效益。该干预措施通过零成本医疗保险套餐为从事交易性性行为的妇女及其经济受抚养人提供免费医疗保健。我们考虑了不同的人群覆盖水平(0%、25%、50%、75%和100%),探讨了这种干预措施的成本效益。我们计算了每避免一个残疾调整生命年(DALY)和每避免一例艾滋病毒感染的增量成本效益比(ICER),采用了单变量和全局敏感性分析。概率敏感性分析考虑了所有参数,包括保险在减少艾滋病毒方面的效果,将模拟的ICER与支付意愿阈值进行比较。我们还将医疗保险策略与扩大暴露前预防(PrEP)覆盖范围进行了比较。所有成本均以2023年英镑(£)为单位进行评估,使用3%的贴现率,喀麦隆人均国内生产总值(GDP)记录为1239英镑。

结果

与0%覆盖相比,实施25%、50%、75%和100%的医疗保险覆盖水平分别产生每避免一个DALY的ICER为2795英镑(2483 - 2824英镑)、2541英镑(2370 - 2592英镑)、2263英镑(2156 - 2316英镑)和1952英镑(1891 - 1998英镑)。概率敏感性分析表明,100%覆盖时每避免一个DALY的ICER = 2128英镑,58%的模拟显示ICER低于人均GDP。将医疗保险在减少艾滋病毒方面的效果维持在70%以上可带来显著的健康和经济效益。然而,在全局敏感性分析中,抗逆转录病毒疗法(ART)的疗效对预防艾滋病毒感染有显著影响(偏秩相关系数 = -0.62,p < 0.001);扩大ART可能会降低医疗保险的成本效益。虽然单独使用PrEP不具有成本效益,但将20%的PrEP覆盖与75% - 100%的从事交易性性行为妇女医疗保险相结合,可最大程度地避免DALY(每避免一个DALY的ICER = 2436 - 2102英镑)并减少感染。

结论

喀麦隆为妇女制定的全面医疗保险计划可显著减少艾滋病毒感染和DALY,促进为艾滋病毒高风险妇女制定更具包容性和针对性的医疗保健政策。

相似文献

1
Cost-effectiveness of health insurance among women engaged in transactional sex and impacts on HIV transmission in Cameroon: a mathematical model.喀麦隆从事性交易女性的健康保险成本效益及其对艾滋病毒传播的影响:一个数学模型
BMJ Glob Health. 2025 Feb 18;10(2):e017870. doi: 10.1136/bmjgh-2024-017870.
2
The impact and cost-effectiveness of combined HIV prevention scenarios among transgender women sex-workers in Lima, Peru: a mathematical modelling study.秘鲁利马跨性别女性性工作者中联合艾滋病毒预防方案的影响和成本效益:一项数学建模研究。
Lancet Public Health. 2019 Mar;4(3):e127-e136. doi: 10.1016/S2468-2667(18)30236-6. Epub 2019 Jan 23.
3
Cost-effectiveness of pre-exposure prophylaxis targeted to high-risk serodiscordant couples as a bridge to sustained ART use in Kampala, Uganda.针对乌干达坎帕拉高危血清学不一致夫妇的暴露前预防作为持续使用抗逆转录病毒疗法的桥梁的成本效益。
J Int AIDS Soc. 2015 Jul 20;18(4 Suppl 3):20013. doi: 10.7448/IAS.18.4.20013. eCollection 2015.
4
The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.非洲喀麦隆保护妇女免受经济冲击以抗击艾滋病毒的效果:POWER 随机对照试验。
PLoS Med. 2024 Oct 24;21(10):e1004355. doi: 10.1371/journal.pmed.1004355. eCollection 2024 Oct.
5
Dapivirine vaginal ring for HIV prevention: modelling health outcomes, drug resistance and cost-effectiveness.双夫定阴道环预防艾滋病毒:建模健康结果、耐药性和成本效益。
J Int AIDS Soc. 2019 May;22(5):e25282. doi: 10.1002/jia2.25282.
6
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.南非异性恋男性中 HIV 暴露前预防的成本效益:成本效用建模分析。
J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):173-181. doi: 10.1097/QAI.0000000000002327.
7
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models.成人抗逆转录病毒疗法提前资格和扩大治疗范围的健康效益、成本和成本效益:12 个数学模型的综合分析。
Lancet Glob Health. 2014 Jan;2(1):e23-34. doi: 10.1016/S2214-109X(13)70172-4. Epub 2013 Dec 10.
8
Cost-effectiveness of HIV pre-exposure prophylaxis among female sex workers in Iran.伊朗女性性工作者中艾滋病病毒暴露前预防的成本效益
Sci Rep. 2025 Mar 5;15(1):7747. doi: 10.1038/s41598-025-92099-1.
9
Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.撒哈拉以南非洲地区孕期及哺乳期艾滋病病毒暴露前预防的成本效益
J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2(Suppl 2):S145-53. doi: 10.1097/QAI.0000000000001063.
10
Cost-effectiveness of interventions for HIV/AIDS, malaria, syphilis, and tuberculosis in 128 countries: a meta-regression analysis.128 个国家艾滋病毒/艾滋病、疟疾、梅毒和结核病干预措施的成本效益:荟萃回归分析。
Lancet Glob Health. 2024 Jul;12(7):e1159-e1173. doi: 10.1016/S2214-109X(24)00181-5.

本文引用的文献

1
The effect of protecting women against economic shocks to fight HIV in Cameroon, Africa: The POWER randomised controlled trial.非洲喀麦隆保护妇女免受经济冲击以抗击艾滋病毒的效果:POWER 随机对照试验。
PLoS Med. 2024 Oct 24;21(10):e1004355. doi: 10.1371/journal.pmed.1004355. eCollection 2024 Oct.
2
Trading HIV for sheep: Risky sexual behavior and the response of female sex workers to Tabaski in Senegal.用艾滋病毒换羊:塞内加尔的女性性工作者在塔巴斯基节期间的危险性行为及其应对措施。
Health Econ. 2024 Jan;33(1):153-193. doi: 10.1002/hec.4756. Epub 2023 Nov 2.
3
Global progress reported for AIDS.
报告称全球在艾滋病防治方面取得进展。
Lancet Infect Dis. 2023 Sep;23(9):e342. doi: 10.1016/S1473-3099(22)00684-3.
4
Transactional sex among women in Sub-Saharan Africa: A systematic review and meta-analysis.撒哈拉以南非洲地区女性间的交易性行为:系统评价和荟萃分析。
PLoS One. 2023 Jun 8;18(6):e0286850. doi: 10.1371/journal.pone.0286850. eCollection 2023.
5
Invisible illness: The consequences of limited health insurance in Africa.隐形疾病:非洲医疗保险有限的后果。
Health Sci Rep. 2023 Jun 1;6(6):e1313. doi: 10.1002/hsr2.1313. eCollection 2023 Jun.
6
Prevalence and factors associated with HIV treatment non-adherence among people living with HIV in three regions of Cameroon: A cross-sectional study.喀麦隆三个地区 HIV 感染者中 HIV 治疗不依从的流行状况及其相关因素:一项横断面研究。
PLoS One. 2023 Apr 4;18(4):e0283991. doi: 10.1371/journal.pone.0283991. eCollection 2023.
7
Technical efficiency of national HIV/AIDS spending in 78 countries between 2010 and 2018: A data envelopment analysis.2010年至2018年78个国家国家艾滋病毒/艾滋病支出的技术效率:数据包络分析
PLOS Glob Public Health. 2022 Aug 1;2(8):e0000463. doi: 10.1371/journal.pgph.0000463. eCollection 2022.
8
The declining trend in HIV prevalence from population-based surveys in Cameroon between 2004 and 2018: myth or reality in the universal test and treat era?喀麦隆 2004 年至 2018 年基于人群的调查中 HIV 流行率呈下降趋势:普遍检测和治疗时代的是神话还是现实?
BMC Public Health. 2023 Mar 13;23(1):479. doi: 10.1186/s12889-023-15374-8.
9
Impact and cost-effectiveness of the national scale-up of HIV pre-exposure prophylaxis among female sex workers in South Africa: a modelling analysis.国家扩大南非女性性工作者艾滋病毒暴露前预防规模的影响和成本效益:建模分析。
J Int AIDS Soc. 2023 Feb;26(2):e26063. doi: 10.1002/jia2.26063.
10
Approaches to improving the efficiency of HIV programme investments.提高艾滋病项目投资效率的方法。
BMJ Glob Health. 2022 Sep;7(9). doi: 10.1136/bmjgh-2022-010127.